Uveal Melanoma in Portugal: Incidence Trends and Geographical Analysis
DOI:
https://doi.org/10.48560/rspo.33228Keywords:
Incidence, Melanoma/epidemiology, Portugal, Uveal Neoplasms/epidemiologyAbstract
INTRODUCTION: Uveal melanoma (UM) is the most common intraocular malignancy in adults. Despite successful local treatments, long-term survival is still a challenge, making early diagnosis of paramount importance. Comprehension of geographical disparities can influence disease surveillance and prognostic counseling. This study aimed to report UM incidence trends and to analyze their geographical variation in Portugal.METHODS: A prospective, observational study was conducted at the Portuguese UM referral center between July 2013 and December 2022. Crude incidence rates and age-standardized incidence rates (ASIR) were calculated. Overall survival (OS) and disease-specific survival (DSS) were estimated and a multivariate Cox analysis was performed to evaluate the effect of tumor characteristics and patient demographics on survival.
RESULTS: A total of 316 patients were included. The mean age at diagnosis was 61.8±14.2 years. The Health Region (HR) of Lisbon and the Tejo River was responsible for most referrals to our center (n=119, 37.7%). Overall ASIR in Portugal was 2.4 cases per million people (95% CI: 2.1-2.8). Higher crude incidence rates were noted in the central coastal districts (5.4 per million people in Aveiro (95% CI: 3.3-7.5) compared with the southern districts (1.0 per million in Faro (95% CI: 0.2-1.7). Geographical analysis showed incidence variation across HR, with the Centro region presenting a higher incidence crude rate (4.0 per million). The 5-year OS rate was 84.6% (95% CI: 78.7-91.1). No significant differences were found in OS (p=0.74) or DSS (p=0.83) when the data was stratified by HR. Cox regression analysis revealed that only basal tumor dimension was significantly associated with lower OS and DSS (HR= 1.33, p<0.001).
CONCLUSION: This is the first study to report the incidence of UM and to analyze regional incidence rates in Portugal. Overall ASIR of UM indicates no sex predilection and lower incidence rates compared to the ones reported in Northern European countries. Geographical variation of crude incidence rates revealed the highest in central coastal districts of Portugal, but no significant differences were found in OS or DSS by Health region or district. Basal tumor diameter was the only predictor of DSS in UM for the Portuguese population in this analysis.
Downloads
References
Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye. 2017;31:241–257
Damato EM, Damato BE. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. Ophthalmology 2012; 119(8): 1582–1589.
Naseripour M, et al. Global Incidence and Trend of Uveal Melanoma from 1943-2015: A Meta-Analysis. Asian Pac J Cancer Prev. 2023;5:1791-1801
Ghazawi FM, Darwich R, Le M, Rahme E, Zubarev A, Moreau L, Burnier JV, Sasseville D, Burnier MN, Litvinov IV. Uveal melanoma incidence trends in Canada: a national comprehensive population-based study. Br J Ophthalmol. 2019;0:1–5
Aronow ME, Topham AK, Singh AD. Uveal melanoma: 5 year update on incidence, treatment, and survival (SEER 1973–2013). Ocular Oncology and Pathology. 2018;4(3):145-151.
Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012;32(7):1363–1372
Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, EUROCARE Working Group et al. Incidence of uveal melanoma in Europe. Ophthalmology 2007; 114: 2309–2315.
Alfaar AS, Saad A, Wiedemann P, Rehak M. The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1723-1731.
Andreoli MT, Mieler WF, Leiderman YI. Epidemiological trends in uveal melanoma. Br J Ophthalmol 2015; 99(11):1550–1553.
Beasley A, Preen D, McLenachan S, Gray E, Chen F. Incidence and mortality of uveal melanoma in Australia (1982–2014). Br J Ophthalmol. 2023;107:406–411.
Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011 Sep;118(9): 1881–5.
Baily C, O'Neill V, Dunne M, Cunningham M, Gullo G, Kennedy S, Walsh PM, Deady S, Horgan N. Uveal Melanoma in Ireland. Ocul Oncol Pathol. 2019 Apr;5(3):195-204.
Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012;32(7):1363–1372
Xu Y, et al. Epidemiological Study of Uveal Melanoma from US Surveillance, Epidemiology, and End Results Program (2010–2015). Journal of Ophthalmology. 2020:1-8
Kaliki S, Shields CL, Shields JA. Uveal melanoma: estimating prognosis. Indian J Ophthalmol. 2015 Feb;63(2):93-102
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Sociedade Portuguesa de Oftalmologia

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.
To obtain the Conflict of Interest file (ICMJE template), click here